| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −272.4× | −1.7× | |
| Price / Book | 33.1× | 2.0× | |
| Price / Sales | 24.6× | 3.9× | |
| Price / Free cash flow | 519.8× | −1.6× | |
| EV / EBITDA | −253.2× | −1.1× | |
| Earnings yield | −0.4% | −14.6% | |
| Free cash flow yield | 0.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,251.65 |
| −0.43% |
| $1.18T |
| 57.3× |
| 77.8% |
| +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.27 | −0.50% | $612.76B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.43 | −0.35% | $502.62B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $404.75 | +0.83% | $363.3B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.30 | −1.13% | $356.01B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.54 | −0.05% | $278.49B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.85 | −0.34% | $255.67B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.21 | −1.42% | $251.51B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.19 | −0.99% | $231.49B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.51 | −1.08% | $191.59B | 22.8× | 37.5% | +32.0% |
